DexCom Inc

DexCom Inc. a medical device company focuses on the design development and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7 integrated CGM systems for diabetes management; Dexcom Share a remote monitoring system; Dexcom Real-Time API which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices for specific and permitted use cases including non-medical device applications medical device data analysis integrated continuous glucose monitoring systems (iCGM) secondary display alarms active patient monitoring and treatment decisions; and Dexcom ONE that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. DexCom Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists physicians and diabetes educators. DexCom Inc. was incorporated in 1999 and is headquartered in San Diego California.